OHRP - OHR Pharmaceutical, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue9/30/20189/30/20179/30/20169/30/2015
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development4,319.16517,406.86916,460.7148,777.519
Selling General and Administrative3,634.4745,278.2727,656.3277,509.601
Non Recurring----
Others----
Total Operating Expenses9,078.20823,850.8325,306.31717,466.374
Operating Income or Loss-9,078.208-23,850.83-25,306.317-17,466.374
Income from Continuing Operations
Total Other Income/Expenses Net-4,158.69239.834-459.8812,268.509
Earnings Before Interest and Taxes-9,078.208-23,850.83-25,306.317-17,466.374
Interest Expense--29.574-29.574-5.977
Income Before Tax-13,236.9-23,810.996-25,766.198-15,197.865
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-13,236.9-23,810.996-25,766.198-15,197.865
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-13,236.9-23,810.996-25,766.198-15,197.865
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-13,236.9-23,810.996-25,766.198-15,197.865